Health Services Research and Managerial Epidemiology

Health Services Research and Managerial Epidemiology was a peer-reviewed, open-access journal issued by SAGE Publications between 2014 and 2024.《健康服务研究与管理流行病学》是一本同行评审的开放获取期刊，2014 至 2024 年间由 SAGE Publications 发行。

The title names its two fields outright, and the papers it carried sat where the organisation and financing of care meet the measurement of population health.刊名直言所指的两个领域，所载论文落在医疗服务的组织与筹资同人群健康测量相交的地带。

Thousand Oaks, California, was the recorded place of publication, and the archive holds 270 articles in eleven annual volumes.记录在案的出版地是加利福尼亚州千橡市，全部存稿共 270 篇，分属 11 个年度卷。

Clarivate gives the title a 2025 Journal Impact Factor of 3.3 and a five-year figure of 2.5, with a rank of 28 among 125 journals in HEALTH POLICY & SERVICES.Clarivate 为该刊记 2025 年影响因子 3.3，五年影响因子 2.5，并在 HEALTH POLICY & SERVICES 类目的 125 种期刊中列第 28 位。

Because the last volume closed in 2024, those numbers describe a fixed body of work, and the 2025 tally of new articles is zero.最后一卷在 2024 年收束，这些数字因此描述一个固定的文本集合，2025 年的新增载文为零。

Scope

• Health services research, the first half of the remit, follows how care is financed, organised, delivered and paid for, and what those arrangements do to outcomes.健康服务研究是范围的前一半，追查医疗服务如何筹资，如何组织，如何提供与付费，以及这些安排对结局产生什么影响。

• Access, cost, quality and equity belong to that field, so work on insurance coverage or on waiting times falls inside it without argument.可及性，费用，质量与公平属于这一领域，保险覆盖或候诊时间一类的研究无需争议即在其内。

• Managerial epidemiology, the second half, turns epidemiologic method on decisions taken by managers, planners and purchasers instead of on aetiology alone, which is the gap between asking why a disease occurs and asking what a service should do about it.管理流行病学是范围的另一半，把流行病学方法用于管理者，规划者与采购方所作的决策，而不止于病因研究，问的是服务该怎样应对，而非疾病为何发生。

• Population health assessment, the projection of demand and the evaluation of programmes all rest on that method, which is why the two halves share one cover.人群健康评估，需求预测与项目评价都依托这套方法，两半合于一刊，理由就在这里。

• Service organisation and governance count as fit subjects, from hospital reconfiguration to primary care networks and the contracts that hold them together.服务组织与治理被视为正当题目，从医院重组到基层医疗网络，再到把这些网络联结起来的合约。

• Health policy analysis is read next to management, so a paper on reform legislation may sit beside one on how a single clinic absorbed the change.卫生政策分析与经营管理并读，讨论改革立法的论文可与讨论某一家诊所如何消化这项改革的论文相邻。

• Health economics appears where it informs a purchasing or staffing choice, which keeps the emphasis on decisions rather than on theory.卫生经济学出现在能够支撑采购或人员配置取舍的位置，重心因此落在决断之上，而非理论推演。

• Quality improvement and patient safety form a standing strand, and the measurement of adverse events is as welcome as the intervention meant to reduce them.质量改进与患者安全构成常设的一条线索，不良事件的测量与旨在减少不良事件的干预同样受到欢迎。

• Health information systems supply much of the evidence, so studies of registries, claims files and electronic records were within reach.卫生信息系统提供大部分证据，登记数据库，理赔档案与电子病历之类的研究因此都在范围之内。

• Workforce questions, from staffing ratios to the regional distribution of clinicians, link management to epidemiology in the way the title invites.人力配置问题从人员配比延伸到临床人员的地域分布，把经营管理与流行病学连在一起，刊名本身就邀请这类稿件。

• Delivery under constraint is admitted as well, since planning with scarce resources is where the managerial side of the field is tested hardest.资源紧缺条件下的服务提供也在接纳之列，正是在这种条件里，该领域的管理一侧受到最严的检验。

• Quantitative, qualitative and mixed designs all appear in the archive, and a single-site case study is judged on the argument it supports rather than on its sample.定量，定性与混合设计在存稿中都能找到，针对单一站点的案例研究按其支撑的论证来评判，而非按样本规模。

• The article types were plain, original research, review and commentary, and each was expected to leave the reader with something actionable rather than a restatement of what was already known.体裁相对朴素，原创研究，综述与评论，每一类都要求收尾处留下读者可以着手的内容，而非把已知的东西再复述一遍。

History

• Volume one appeared in 2014 under SAGE Publications, and the same house carried the title to its last issue.第 1 卷于 2014 年在 SAGE Publications 名下问世，此后直到终刊都由同一家出版。

• The National Library of Medicine dates coverage from volume 1, January to December 2014, and PubMed Central holds the deposited text.美国国家医学图书馆把收录起点定在第 1 卷，即 2014 年 1 月至 12 月，PubMed Central 存有已缴存的全文。

• Each year added one volume and filled it without issue numbers, so volume 11 in 2024 closed a run of eleven volumes and 270 articles, a little over two dozen papers to a volume.每年增加一卷，卷内不编期号，2024 年的第 11 卷因此收束了 11 卷与 270 篇的序列，平均每卷二十余篇。

• Articles carried numbers and went out as they were accepted, an arrangement that let a volume grow across the year and spared authors a wait for a fixed slot.文章以编号标识，一经录用即行发布，每一卷因此得以在一年之中陆续增长，作者不必等一个固定的版面位置。

• The title was listed in the Emerging Sources Citation Index, the Clarivate subset reserved for journals still under review for the older indexes.该刊被列入 Emerging Sources Citation Index，这是 Clarivate 为仍在接受考察的期刊所设的子集。

• The impact factor stood at 1.5 in 2023 and again in 2024, and the 2025 assessment raised it to 3.3 after publication had ended.影响因子 2023 年为 1.5，2024 年仍为 1.5，2025 年的评估把它抬到 3.3，此时出版已经结束。

• That late rise rests on citations to material already in print, since nothing new entered the denominator, and the cited half-life is 3.7 years.这一滞后上升来自对已刊材料的引用，分母里没有增加新论文，被引半衰期记为 3.7 年。

• Cumulative citations reached 457, a modest total that suits a journal of 270 articles on a subject whose citing literature is itself small, and the count can now grow only from the back catalogue.累计被引 457 次，数目不算大，与一份 270 篇，且引用方文献本身规模有限的刊物相称，此后的增长只能来自旧有存稿。

• Publication ceased with volume 11 in 2024, the final deposits carrying dates in September of that year, and the NLM record now marks the title as no longer indexed.出版止于 2024 年第 11 卷，最后一批缴存记录的时间在当年 9 月，美国国家医学图书馆现标注该刊不再收录。

• The NLM imprint reads [2014]-[2024], and the record simply stops at that year.NLM 的出版项记为 [2014]-[2024]，记录就停在这一年。

• Reading cost nothing throughout the run, and Clarivate records the gold share of output at 100 per cent, so the archive stays open after the end.全程阅读不收费用，Clarivate 记录的金色开放获取比例为 100%，停刊之后整个存稿仍然开放。

• In its last assessment the title held first quartile standing, with a JCI of 0.72 and a percentile of 78 among health policy journals.在最后一次评估中该刊保持第一四分位，JCI 为 0.72，在卫生政策类期刊中百分位为 78。

Editors

• The journal called itself peer reviewed, and a research paper went to outside referees before any editorial decision was reached.该刊自述为同行评审期刊，研究论文在编辑决定形成之前送给外部评审人。

• Referees were asked to weigh method and policy relevance together, since a sound study with no managerial use was a poor fit for the title.评审人需要同时衡量方法与政策相关性，方法站得住却无管理用途的研究与这份刊名不合。

• A remit spanning two fields needed readers from both, so health services research, epidemiology and health management supplied the pool.跨越两个领域的范围需要两侧的评审人，健康服务研究，流行病学与卫生管理三个方向共同提供人选。

• Original research, reviews and commentary were handled differently, and a review was judged on its coverage of a literature rather than on new data.原创研究，综述与评论的处理方式不同，综述按对某一文献脉络的覆盖来评判。

• Submissions went through the publisher's online system, where authors declared competing interests and named the funder of the work.稿件经出版方的在线系统提交，作者在其中申报利益冲突并写明研究的资助方。

• A revision was expected to answer each point raised, and the response letter travelled back to the referees with the marked manuscript.修改稿须逐条回应所提意见，答复信与标注过的稿件一同回到评审人手中。

• Where a paper straddled management and clinical practice, the handling editor could take a further opinion instead of forcing one verdict.若论文横跨管理与临床两端，责任编辑可以另取一份意见，不必强行给出单一判断。

• Authors who disputed a decision could ask for it to be seen again by an editor outside the first round.对决定有异议的作者可以请求由未经首轮的编辑再看一遍。

• Publication carried no subscription barrier, and the cost was met by an article processing charge paid once a paper was accepted.出版环节没有订阅屏障，成本由录用后支付的文章处理费承担。